MarketResearchReports.Biz announces the addition of a new report to its vast repository of research studies. The report is titled “ Global Protein Therapeutics Market 2016-2020”.

Albany, NY -- (SBWire) -- 12/11/2015 --Market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market. The monoclonal antibodies can be prepared specific to any cell surface or extracellular target. These antibodies are being used in radioimmunotherapy and antibody-directed enzyme prodrug therapy. Monoclonal antibodies are also used in the formulation of various biopharmaceutical drugs for the treatment of different diseases such as cancer, rheumatoid arthritis, multiple sclerosis, and UC.

The availability of favorable reimbursement policies in this market is expected to boost the market growth during the forecast period. Protein therapeutics are expensive and cannot be afforded by all, but reimbursement of the diagnostic kits and biologic drugs are expected to fuel the market during the forecast period. Plans like the public reimbursement programs reduce the financial burden of treatments. The reimbursement status of drugs varies from region to region, with factors such as lack of cost-effectiveness impeding the coverage.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/476998

Product segmentation and analysis of the protein therapeutics market

Monoclonal antibodies
Erythropoietin
Insulin
Human growth hormone
Interferons
Blood clotting factor
G-CSF
Follicle stimulating hormone
The monoclonal antibodies segment dominated the market during 2015, with a market share of 55%. An increase in the prevalence of cancer and autoimmune diseases, increase in research activities, and increased technological advancement in the development of next-generation antibodies are the main factors fueling the growth of this segment.

Geographical segmentation and analysis of the protein therapeutics market

Americas
APAC
EMEA
The Americas accounted for 48% of the market share during 2015 and is expected to grow at a CAGR of 7% during the forecast period. The promising public health approaches by the government, growing incidence, and an increase in regulatory support for the development of protein therapeutics are the primary drivers for the market growth in this region.

Competitive landscape and key vendors

The global protein therapeutics market is highly fragmented due to the presence of numerous small and large vendors. The vendors in the market compete on the basis of price, quality, and innovation. Competition among the vendors has led an increased number of M&A, wherein smaller entities are being acquired by, or are being merged with, major players.

The leading vendors in the market are -

AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Novo Nordisk

Other prominent vendors in the market include Anhui Anke Biotechnology, AstraZeneca, Baxter International, Biocon, Biodel, Biogenomics, BioPartners, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion, Chugai Pharmaceutical, Diamyd Medical, Diasome Pharmaceuticals, DiaVacs, Dynavax Technologies, Eli Lilly, Ferring Pharmaceuticals, Generex Biotechnology, GeneScience Pharmaceuticals, Hualan Biological Engineering, Intas Pharmaceuticals, Ipsen, JCR Pharmaceuticals, Kyowa Hakko Kirin, Lexicon Pharmaceuticals, LG Life Sciences, Macrogenics, MannKind, Oramed Pharmaceuticals, Osiris Therapeutics, Pfizer, Sandoz International, Sanofi, Teva Pharmaceutical Industries, Thermalin Diabetes, Tolerion, Wockhardt, and XOMA.

Key questions answered in the report include

What will the market size and the growth rate be in 2020
What are the key factors driving the global protein therapeutics market
What are the key market trends impacting the growth of the protein therapeutics market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the vendors in the global protein therapeutics market
Trending factors influencing the market shares of the Americas, APAC, and EMEA
What are the key outcomes of the five forces analysis of the protein therapeutics market

Related reports:

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019
Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019
Global Cephalosporin Drugs Market 2015-2019
Global Cancer Biomarkers Industry 2015
Immunodiagnostic Market in China 2015-2019

About MarketResearchReports.Biz
MarketResearchReports.biz is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profiles in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, MarketResearchReports.biz has built a veritable reputation for fulfilling the most exacting market research needs.

Contacts

MarketResearchReports.biz
Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@marketresearchreports.biz
http://www.marketresearchreports.biz